Structure-based design of pan-coronavirus inhibitors targeting host cathepsin L and calpain-1

Abstract excerpt

Abstract Respiratory disease caused by coronavirus infection remains a global health crisis. Although several SARS-CoV-2-specific vaccines and direct-acting antivirals are available, their efficacy on emerging coronaviruses in the future, including SARS-CoV-2 variants, might be compromised. Host-targeting antivirals provide preventive and therapeutic strategies to overcome resistance and manage future outbreak of...

Topics

Share this publication in a Topic to start or enrich a Post.

• Share to Calpain Protease Function and Regulation
• Share to interferon and immune responses
• Share to SARS-CoV-2 and COVID-19 Research